Fig. 8
In vivo tumor-targeting capability and antitumor efficacy of 131I-fulvestrant-ALA-PFP-FA-NPs: A Detection and biodistribution of nanoparticle targeting to tumors at different time points after intravenous injection of 125I-fulvestrant-ALA-PFP-NPs Using SPECT/CT. B PET/CT analysis of FDG uptake in tumor tissues before and after various treatment groups. (Values are Mean ± S.D., n = 5)